The Brainchip Story -Chapter One, page-5

Chapter Four

While all this has been taking place Peter van der Made having completed the AKD1000 design has with Anil Mankar moved on to the designs for AKD2000 and AKD3000 while at the same time working with Adam Osseiran and others on the AERO project. The AERO project started life as a way to leverage the ADE to identify gases and in the process created a design for a scientific instrument powered by the ADE using only 200 AKIDA neurons which was capable of state of the art identification of the 20 gas data set (of ten gases) with latency of only 3 seconds.This breakthrough research has led to trialling the ADE as the (processor) for identifying Volatile Organic Compounds of various diseases from samples of exhaled human breath. As luck would have it Adam Osseiran’s work with Noble Laureate Professor Barry Marshall on the invention of the Noisy Gut Belt has led to Professor Marshall becoming aware of the AKIDA technology and accepting an invitation to join the BrainChip Scientific Advisory Board for the purpose of developing medical diagnostic applications relating to AERO and its proven capacity to identify gases for the purpose of identify various medical conditions in real time from sampling exhaled human breath.The Brainchip Scientific Advisory Board is presently chaired by Adam Osseiran with Professor Barry Marshall and Dr. Simon Thorpe. In a presentation by Peter van der Made to the Brain Inspired Computing Congress in November, 2020 he confirmed that AKIDA had been successfully implemented as the processor for the purpose of identifying Covid-19 with a success rate of 94%.It is well recognised that various diseases including some cancers, diabetes and Covid-19 express themselves in identifiable patterns when exhaled on an infected person’s breath. The potential low cost, unconnected, portable nature of an AKIDA medical scientific instrument for this purpose could be life changing for remote populations and people of developing countries.The ability to incorporate this technology into telehealth applications which have grown exponentially in developed countries as a result of Covid-19 infection promises huge commercial opportunities and together these factors could provide greater equality of access to modern medical services than at any time in history of the world.In fact researchers at Australia’s own Flinders’ University have in recent months announced that they have identified VOC markers in exhaled human breath for head and neck cancer.